Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:RKDA NYSE:UAN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeRKDAArcadia Biosciences$0.69+2.2%$0.98$0.65▼$6.71$1.39M0.516.37 million shs47,544 shsUANCVR Partners$109.60+0.0%$122.25$84.13▼$139.50$1.16B0.1347,748 shs28,984 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceRKDAArcadia Biosciences+2.16%-11.29%-25.45%-53.09%-83.46%UANCVR Partners+0.10%-1.51%-10.26%-19.62%+20.82%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeRKDAArcadia Biosciences$0.69+2.2%$0.98$0.65▼$6.71$1.39M0.516.37 million shs47,544 shsUANCVR Partners$109.60+0.0%$122.25$84.13▼$139.50$1.16B0.1347,748 shs28,984 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceRKDAArcadia Biosciences+2.16%-11.29%-25.45%-53.09%-83.46%UANCVR Partners+0.10%-1.51%-10.26%-19.62%+20.82%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceRKDAArcadia Biosciences 1.00SellN/AN/AUANCVR Partners 3.00BuyN/AN/ACurrent Analyst Ratings BreakdownLatest UAN, WYN, and RKDA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/25/2026RKDAArcadia Biosciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/11/2026RKDAArcadia Biosciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/21/2026RKDAArcadia Biosciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/14/2026UANCVR Partners Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C) ➝ Buy (B)5/6/2026RKDAArcadia Biosciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/22/2026RKDAArcadia Biosciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)(Data available from 6/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookRKDAArcadia Biosciences$4.86M0.29$1.33 per share0.52$2.39 per share0.29UANCVR Partners$606.04M1.91$17.15 per share6.39$25.14 per share4.36Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateRKDAArcadia Biosciences-$2.34M-$5.73N/AN/AN/A-195.94%-113.73%-68.47%8/19/2026 (Estimated)UANCVR Partners$98.66M$11.509.53N/AN/A18.89%40.08%12.08%7/29/2026 (Estimated)Latest UAN, WYN, and RKDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026RKDAArcadia Biosciences-$0.80-$2.11-$1.31-$2.11$1.60 million$1.10 million4/29/2026Q1 2026UANCVR PartnersN/A$4.72N/A$4.72N/A$180.05 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthRKDAArcadia BiosciencesN/AN/AN/AN/AN/AUANCVR Partners$16.0014.60%N/A139.13%1 YearsLatest UAN, WYN, and RKDA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/29/2026UANCVR Partnersquarterly$4.0012.19%5/11/20265/11/20265/18/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioRKDAArcadia BiosciencesN/A3.793.17UANCVR Partners1.832.751.86Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipRKDAArcadia Biosciences17.73%UANCVR Partners43.83%Insider OwnershipCompanyInsider OwnershipRKDAArcadia Biosciences8.20%UANCVR Partners0.36%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableRKDAArcadia Biosciences602.06 million1.89 millionNot OptionableUANCVR Partners30010.57 million10.53 millionOptionableUAN, WYN, and RKDA HeadlinesRecent News About These CompaniesCVR Energy, CVR Partners CFO Neumann to become president/CEO; Pytosh departsJune 22, 2026 | msn.comCVR Partners LP (UAN): Carl C. Icahn Reiterates Bullish StanceMay 14, 2026 | finance.yahoo.comIs CVR Partners (UAN) Offering Value After 76.8% One‑Year Share Price Gain?May 6, 2026 | finance.yahoo.comA Look At CVR Partners (UAN) Valuation After Strong Q1 Results And Ammonia Expansion PlansMay 5, 2026 | finance.yahoo.comThe Bull Case For CVR Partners (UAN) Could Change Following Strong Q1 Payout And Utilization OutlookMay 5, 2026 | finance.yahoo.comCVR Partners, LP (NYSE:UAN) Q1 2026 Earnings Call TranscriptMay 2, 2026 | insidermonkey.comCvr Partners (UAN) Q1 2026 Earnings TranscriptMay 2, 2026 | fool.comCvr partners expects Q2 2026 ammonia utilization at 95%-100% while projecting $60M-$75M in 2026 capexMay 2, 2026 | seekingalpha.comCVR Partners, LP Common Units (UAN) Q1 2026 Earnings Call Prepared Remarks TranscriptApril 30, 2026 | seekingalpha.comCVR Partners Reports First Quarter 2026 ResultsApril 29, 2026 | businesswire.comMispriced CVR Partners Looks Ready To GrowApril 25, 2026 | seekingalpha.comTop 3 fertilizer stocks to buy in AprilApril 17, 2026 | finbold.comFCVR Partners Posts Q4 Loss But Maintains 2025 PayoutsMarch 31, 2026 | theglobeandmail.comCF, UAN stocks rally on supply shock due to Middle East disruptions – here’s why analysts see further upsideMarch 27, 2026 | msn.comIran Conflict Tightens Fertilizer Supply And Lifts CVR Partners OutlookMarch 18, 2026 | finance.yahoo.comCVR Partners (NYSE:UAN) Reaches New 52-Week High – Here’s WhyMarch 8, 2026 | defenseworld.netDCVR Partners Faces NYSE Non‑Compliance After Director’s DeathMarch 3, 2026 | tipranks.comCVR Partners, LP (NYSE:UAN) Q4 2025 earnings call transcriptFebruary 20, 2026 | msn.comCVR Partners targets 95%-100% ammonia utilization in Q1 2026 as reliability projects advanceFebruary 20, 2026 | seekingalpha.comCVR Partners LP (UAN) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...February 20, 2026 | uk.finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Case for Intel Over Pure-Play Quantum FirmsBy Nathan Reiff | June 9, 2026What IBM's $10-Billion Quantum Project Means For Smaller PlayersBy Nathan Reiff | June 3, 2026Marvell Stock Soars on NVIDIA's Trillion-Dollar NodBy Jeffrey Neal Johnson | June 2, 20263 Stocks Cashing In on AI While Everyone Watches NVIDIABy Bridget Bennett | June 11, 2026Why These Three Big Buybacks Are Sending Very Different Signals to InvestorsBy Leo Miller | June 1, 2026UAN, WYN, and RKDA Company DescriptionsArcadia Biosciences NASDAQ:RKDA$0.69 +0.01 (+2.16%) As of 06/26/2026 04:00 PM EasternArcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.CVR Partners NYSE:UAN$109.60 +0.05 (+0.04%) Closing price 06/26/2026 03:59 PM EasternExtended Trading$105.66 -3.94 (-3.59%) As of 06/26/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.CVR Partners, LP, together with its subsidiaries, engages in the production and sale of nitrogen fertilizer products in the United States. The company offers ammonia products for agricultural and industrial customers; and urea ammonium nitrate products to agricultural customers, as well as retailers and distributors. CVR GP, LLC serves as the general partner of the company. CVR Partners, LP was incorporated in 2007 and is based in Sugar Land, Texas. CVR Partners, LP is a subsidiary of CVR Energy, Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Rocket Lab's NASA Win Tests Key Support After Sharp Pullback BlackBerry’s Rally Is Running on a Bigger AI Story Than Earnings Alone Fabrinet Is Becoming a Quiet Winner in the AI Optics Buildout Palantir’s Valuation Problem Just Met 2 New Growth Catalysts Micron’s HBM Surge Could Redefine the AI Growth Story Carnival's Second Quarter: Is the Stock Still Complicated? Xcel Energy Stock Offers Stability as Electricity Demand Builds Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
